The biology of aggressive behavior in bipolar disorder: A systematic review

Giovanna Fico; Gerard Anmella; Isabella Pacchiarotti; Norma Verdolini; Maria Sagué-Vilavella; Filippo Corponi; Mirko Manchia; Eduard Vieta; Andrea Murru

doi:10.1016/j.neubiorev.2020.09.015

The biology of aggressive behavior in bipolar disorder: A systematic review

Giovanna Fico, Gerard Anmella, Isabella Pacchiarotti, Norma Verdolini, Maria Sagué-Vilavella, Filippo Corponi, Mirko Manchia, Eduard Vieta, Andrea Murru

Research output: Contribution to journal › Review article › peer-review

18 Citations (Scopus)

Original language	English
Pages (from-to)	9-20
Number of pages	12
Journal	Neuroscience and Biobehavioral Reviews
Volume	119
DOIs	https://doi.org/10.1016/j.neubiorev.2020.09.015
Publication status	Published - Dec 2020
Externally published	Yes

ASJC Scopus Subject Areas

Neuropsychology and Physiological Psychology
Cognitive Neuroscience
Behavioral Neuroscience

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.neubiorev.2020.09.015

Cite this

@article{6d63853415304de2aa610f2525d23d18,

title = "The biology of aggressive behavior in bipolar disorder: A systematic review",

author = "Giovanna Fico and Gerard Anmella and Isabella Pacchiarotti and Norma Verdolini and Maria Sagu{\'e}-Vilavella and Filippo Corponi and Mirko Manchia and Eduard Vieta and Andrea Murru",

note = "Funding Information: EV has received grants and served as consultant, advisor or CME speaker for the following entities: Abbott, Allergan, Angelini, Dainippon Sumitomo Pharma, Janssen, Lundbeck, Novartis, Otsuka, Richter, Sage, Sanofi-Aventis, and Takeda. AM has received a grant (PI19/00672) from the Instituto de Salud Carlos IIISubdirecci{\'o}n General de Evaluaci{\'o}n y Fomento de la investigaci{\'o}n, Plan Nacional 2019-2022. IP has received CME-related honoraria, or consulting fees from ADAMED, Janssen-Cilag and Lundbeck and reports no financial or other relationship relevant to the subject of this article.EV thanks the support of the Spanish Ministry of Science, Innovation (PI15/00283, PI18/00805) integrated into the Plan Nacional de I + D+I y cofinanciado por el ISCIIISubdirecci{\'o}n General de Evaluaci{\'o}n y el Fondo Europeo de Desarrollo Regional (FEDER); CIBERSAM; and the Comissionat per a Universitats i Recerca del DIUE de la Generalitat de Catalunya to the Bipolar Disorders Group (2017 SGR 1365) and the project SLT006/17/00357, from PERIS 2016-2020 (Departament de Salut). Funding Information: EV thanks the support of the Spanish Ministry of Science, Innovation ( PI15/00283 , PI18/00805 ) integrated into the Plan Nacional de I + D+I y cofinanciado por el ISCIIISubdirecci{\'o}n General de Evaluaci{\'o}n y el Fondo Europeo de Desarrollo Regional (FEDER); CIBERSAM; and the Comissionat per a Universitats i Recerca del DIUE de la Generalitat de Catalunya to the Bipolar Disorders Group (2017 SGR 1365) and the project SLT006/17/00357, from PERIS 2016-2020 (Departament de Salut). Publisher Copyright: {\textcopyright} 2020 Elsevier Ltd",

year = "2020",

month = dec,

doi = "10.1016/j.neubiorev.2020.09.015",

language = "English",

volume = "119",

pages = "9--20",

journal = "Neuroscience and Biobehavioral Reviews",

issn = "0149-7634",

publisher = "Elsevier Limited",

}

TY - JOUR

T1 - The biology of aggressive behavior in bipolar disorder

T2 - A systematic review

AU - Fico, Giovanna

AU - Anmella, Gerard

AU - Pacchiarotti, Isabella

AU - Verdolini, Norma

AU - Sagué-Vilavella, Maria

AU - Corponi, Filippo

AU - Manchia, Mirko

AU - Vieta, Eduard

AU - Murru, Andrea

N1 - Funding Information: EV has received grants and served as consultant, advisor or CME speaker for the following entities: Abbott, Allergan, Angelini, Dainippon Sumitomo Pharma, Janssen, Lundbeck, Novartis, Otsuka, Richter, Sage, Sanofi-Aventis, and Takeda. AM has received a grant (PI19/00672) from the Instituto de Salud Carlos IIISubdirección General de Evaluación y Fomento de la investigación, Plan Nacional 2019-2022. IP has received CME-related honoraria, or consulting fees from ADAMED, Janssen-Cilag and Lundbeck and reports no financial or other relationship relevant to the subject of this article.EV thanks the support of the Spanish Ministry of Science, Innovation (PI15/00283, PI18/00805) integrated into the Plan Nacional de I + D+I y cofinanciado por el ISCIIISubdirección General de Evaluación y el Fondo Europeo de Desarrollo Regional (FEDER); CIBERSAM; and the Comissionat per a Universitats i Recerca del DIUE de la Generalitat de Catalunya to the Bipolar Disorders Group (2017 SGR 1365) and the project SLT006/17/00357, from PERIS 2016-2020 (Departament de Salut). Funding Information: EV thanks the support of the Spanish Ministry of Science, Innovation ( PI15/00283 , PI18/00805 ) integrated into the Plan Nacional de I + D+I y cofinanciado por el ISCIIISubdirección General de Evaluación y el Fondo Europeo de Desarrollo Regional (FEDER); CIBERSAM; and the Comissionat per a Universitats i Recerca del DIUE de la Generalitat de Catalunya to the Bipolar Disorders Group (2017 SGR 1365) and the project SLT006/17/00357, from PERIS 2016-2020 (Departament de Salut). Publisher Copyright: © 2020 Elsevier Ltd

PY - 2020/12

Y1 - 2020/12

UR - http://www.scopus.com/inward/record.url?scp=85091995594&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85091995594&partnerID=8YFLogxK

U2 - 10.1016/j.neubiorev.2020.09.015

DO - 10.1016/j.neubiorev.2020.09.015

M3 - Review article

C2 - 32980400

AN - SCOPUS:85091995594

SN - 0149-7634

VL - 119

SP - 9

EP - 20

JO - Neuroscience and Biobehavioral Reviews

JF - Neuroscience and Biobehavioral Reviews

ER -

The biology of aggressive behavior in bipolar disorder: A systematic review

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this